Invention Grant
- Patent Title: Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases
- Patent Title (中): 吡咯并吡啶和吡咯并嘧啶抑制剂的激酶
-
Application No.: US13106076Application Date: 2011-05-12
-
Publication No.: US08691810B2Publication Date: 2014-04-08
- Inventor: Michael R. Michaelides , Andrew S. Judd , Shannon R. Fix-Stenzel , Richard F. Clark , Bryan K. Sorensen , Zhiqin Ji
- Applicant: Michael R. Michaelides , Andrew S. Judd , Shannon R. Fix-Stenzel , Richard F. Clark , Bryan K. Sorensen , Zhiqin Ji
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Michael Best & Friedrich LLP
- Agent Lisa V. Mueller
- Main IPC: A61K31/5513
- IPC: A61K31/5513 ; A61K31/5377 ; A61K31/496 ; A61K31/437 ; C07D471/04 ; C07D243/14 ; A61K31/519 ; C07D487/04 ; A61P35/04
Abstract:
The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein A, B, R1, R2, R3, R4a, R5, and Z are defined in the description. The present invention relates also to methods of making said compounds, and compositions containing said compounds which are useful for inhibiting kinases such as aurora.
Public/Granted literature
- US20110281842A1 PYRROLOPYRIDINE AND PYRROLOPYRIMIDINE INHIBITORS OF KINASES Public/Granted day:2011-11-17
Information query
IPC分类:
